Abiopharma

New Form 8-K/A - BIODESIX INC Filed: 2026-01-12 AccNo: 0001193125-26-010114 Size: 200 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SC 13E3 - CYANOTECH CORP Filed: 2026-01-09 AccNo: 0000947871-26-000021 Size: 315 KB

(10% Negative) Sarepta Therapeutics Inc (SRPT) Announces Delay in revenue Trials for San Francisco Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Sarepta Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues

New Form D - Vireo Growth Inc. Filed: 2026-01-12 AccNo: 0001771706-26-000001 Size: 9 KB

(10% Negative) Lexeo Therapeutics Inc. (LXEO) Announces Delay in treatments Trials for cardiovascular diseases Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(91% Positive) Profound Medical Corp (PROF) Announces Clinical Development Update

Smith+Nephew PLC Notification

Investis Notification - Smith+Nephew PLC

New Form D - SOBR Safe, Inc. Filed: 2026-01-12 AccNo: 0001425627-26-000001 Size: 12 KB

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

New Form 424B5 - China SXT Pharmaceuticals, Inc. Filed: 2026-01-12 AccNo: 0001213900-26-003205 Size: 328 KB

New Form 4/A - CROSS COUNTRY HEALTHCARE INC Filed: 2026-01-12 AccNo: 0001012975-26-000025 Size: 9 KB

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI